Developing top down proteomics to maximize proteome and sequence coverage from cells and tissues
- PMID: 23988518
- PMCID: PMC3878305
- DOI: 10.1016/j.cbpa.2013.07.028
Developing top down proteomics to maximize proteome and sequence coverage from cells and tissues
Abstract
Mass spectrometry based proteomics generally seeks to identify and characterize protein molecules with high accuracy and throughput. Recent speed and quality improvements to the independent steps of integrated platforms have removed many limitations to the robust implementation of top down proteomics (TDP) for proteins below 70 kDa. Improved intact protein separations coupled to high-performance instruments have increased the quality and number of protein and proteoform identifications. To date, TDP applications have shown >1000 protein identifications, expanding to an average of ∼3-4 more proteoforms for each protein detected. In the near future, increased fractionation power, new mass spectrometers and improvements in proteoform scoring will combine to accelerate the application and impact of TDP to this century's biomedical problems.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Figures
References
-
- Aebersold R, Bader GD, Edwards AM, Van Eyk JE, Kussmann M, Qin J, Omenn GS. The biology/disease-driven human proteome project (B/D-HPP): enabling protein research for the life sciences community. Journal of proteome research. 2013;12:23–7. - PubMed
-
- Paik Y-K, Jeong S-K, Omenn GS, Uhlen M, Hanash S, Cho SY, Lee H-J, Na K, Choi E-Y, Yan F, et al. The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome. Nature biotechnology. 2012;30:221–3. - PubMed
-
- Tomiyama S. Experimental autoimmune labyrinthitis: assessment of molecular size of autoantigens in fractions of inner ear proteins eluted on the Mini Whole Gel Eluter. Acta oto-laryngologica. 2002;122:692–7. - PubMed
-
- Garcia B, Pesavento J, Mizzen C, Kelleher N. Pervasive combinatorial modification of histone H3 in human cells. Nature methods. 2007;4:487–489. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
